ASTS

AST SpaceMobile, Inc.

49
Fundamentals66/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential46/ 100

ASTS trails on the overall score without a compensating advantage in the available component scores.

AVPT

AvePoint, Inc.

70
Fundamentals86/ 100
Valuation54/ 100
Upside potential71/ 100
Risk potential17/ 100

AVPT has the edge over ASTS overall, supported by lower modeled downside and stronger fundamentals.

ASTS Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

AVPT Fundamentals

MetricStatus
Healthy
Healthy
Strong
Unavailable

AVPT's revenue, profitability and cash flow are currently healthy. There isn't enough data to rate its balance sheet.

ASTS PE Valuation

ASTS has no meaningful PE right now: it lost money over the past year.

AVPT PE Valuation

CHEAPFAIREXPENSIVE2181x4361x6542x8723x
CHEAPFAIREXPENSIVE2181x4361x6542x8723x
LevelPEPriceVs current
Forward34x$16.38—
Cheap48x$15.89-3%
Current50x$16.38—
Fair66x$21.92+34%
Expensive7,357x$2,428+14722%

Historical ranges are pointers, not guarantees.

AVPT's PE is in its cheap range at 50x. If earnings grow as analysts expect, today's price would be 34x next year's earnings.

ASTS Forward outlook

MetricOutlook
--
Losses growing
Strong growth
--
Limited
Low

Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.

AVPT Forward outlook

MetricOutlook
Strongly improving
Strong growth
Strong growth
Strongly improving
Limited
Low

Analysts expect strong earnings and revenue growth for AVPT, with profitability improving. However, they disagree widely on these estimates.

ASTS Risk to reward

ScenarioChangePrice
Upside+86%$64.16
Downside-46%$18.77

Calculated from the latest close: $34.50 on Nov 12.

ASTS trails AVPT on modeled risk to reward, with less potential upside relative to its potential downside.

AVPT Risk to reward

ScenarioChangePrice
Upside+42%$23.25
Downside-17%$13.62

Calculated from the latest close: $16.38 on Nov 12.

AVPT has a better modeled risk to reward balance than ASTS, with more potential upside relative to its potential downside.

ASTS Earnings Per Share

Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
Q1 2024: $-0.98Q2 2024: $-1.25Q3 2024: $-2.12Q4 2024: $-1.95Q1 2025: $-1.99Q2 2025: $-1.89Q3 2025: $-1.24Q4 2025: $-1.34Q1 2026: $-1.80Q2 2026: $-2.16Q3 2026: $-2.15
QuarterTTM EPSYoY
Q3 2026-$2.15-$0.91
Q2 2026-$2.16-$0.27
Q1 2026-$1.80+$0.19
Q4 2025-$1.34+$0.61
Q3 2025-$1.24+$0.88
Q2 2025-$1.89-$0.64
Q1 2025-$1.99-$1.01
Q4 2022-$0.58-$0.21

ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.

AVPT Earnings Per Share

Q4 2023: $-0.12Q1 2024: $-0.08Q2 2024: $-0.08Q3 2024: $-0.05Q4 2024: $-0.16Q1 2025: $-0.13Q2 2025: $-0.05Q3 2025: $0.00Q4 2025: $0.15Q1 2026: $0.20Q2 2026: $0.31Q3 2026: $0.33Forward: $0.48
Q4 2023: $-0.12Q1 2024: $-0.08Q2 2024: $-0.08Q3 2024: $-0.05Q4 2024: $-0.16Q1 2025: $-0.13Q2 2025: $-0.05Q3 2025: $0.00Q4 2025: $0.15Q1 2026: $0.20Q2 2026: $0.31Q3 2026: $0.33Forward: $0.48
QuarterTTM EPSYoY
Forward$0.48+46%
Q3 2026$0.33+$0.33
Q2 2026$0.31+$0.36
Q1 2026$0.20+$0.33
Q4 2025$0.15+$0.31
Q3 2025$0.00+$0.05
Q2 2025-$0.05+$0.03
Q1 2025-$0.13-$0.05
Q4 2024-$0.16-$0.04

AVPT has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.

ASTS Quarterly Revenue

Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
Q4 2023: $0Q1 2024: $500,000Q2 2024: $900,000Q3 2024: $1MQ4 2024: $2MQ1 2025: $718,000Q2 2025: $1MQ3 2025: $15MQ4 2025: $54MQ1 2026: $15MQ2 2026: $32MQ3 2026: $42M
QuarterRevenueYoY
Q3 2026$42.3M+187%
Q2 2026$31.5M+2627%
Q1 2026$14.7M+1952%
Q4 2025$54.3M+2731%
Q3 2025$14.7M+1240%
Q2 2025$1.2M+28%
Q1 2025$718K+44%
Q3 2022$4.2M+70%

ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.

AVPT Quarterly Revenue

Q4 2023: $75MQ1 2024: $75MQ2 2024: $78MQ3 2024: $89MQ4 2024: $89MQ1 2025: $93MQ2 2025: $102MQ3 2025: $110MQ4 2025: $115MQ1 2026: $117MQ2 2026: $124MQ3 2026: $131M
Q4 2023: $75MQ1 2024: $75MQ2 2024: $78MQ3 2024: $89MQ4 2024: $89MQ1 2025: $93MQ2 2025: $102MQ3 2025: $110MQ4 2025: $115MQ1 2026: $117MQ2 2026: $124MQ3 2026: $131M
QuarterRevenueYoY
Q3 2026$131.1M+19%
Q2 2026$124.5M+22%
Q1 2026$117.2M+26%
Q4 2025$114.7M+29%
Q3 2025$109.7M+24%
Q2 2025$102M+31%
Q1 2025$93.1M+25%
Q4 2024$89.2M+20%

AVPT's revenue has grown year over year every quarter since mid-2022: $131M last quarter, up 19% from the same quarter a year ago.

ASTS Free Cash Flow

Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
Q4 2023: −$47MQ1 2024: −$88MQ2 2024: −$38MQ3 2024: −$64MQ4 2024: −$110MQ1 2025: −$149MQ2 2025: −$354MQ3 2025: −$303MQ4 2025: −$331MQ1 2026: −$310MQ2 2026: −$695MQ3 2026: −$464M
QuarterFree cash flowYoY
Q3 2026-$464.2M-$161.4M
Q2 2026-$694.8M-$341.1M
Q1 2026-$309.7M-$160.7M
Q4 2025-$330.7M-$220.3M
Q3 2025-$302.9M-$239.1M
Q2 2025-$353.6M-$315.3M
Q1 2025-$149M-$61.3M
Q4 2024-$110.5M-$63.2M

ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.

AVPT Free Cash Flow

Q4 2023: $21MQ1 2024: $7MQ2 2024: $16MQ3 2024: $31MQ4 2024: $32MQ1 2025: −$1MQ2 2025: $19MQ3 2025: $34MQ4 2025: $29MQ1 2026: $23MQ2 2026: $15MQ3 2026: $30M
Q4 2023: $21MQ1 2024: $7MQ2 2024: $16MQ3 2024: $31MQ4 2024: $32MQ1 2025: −$1MQ2 2025: $19MQ3 2025: $34MQ4 2025: $29MQ1 2026: $23MQ2 2026: $15MQ3 2026: $30M
QuarterFree cash flowYoY
Q3 2026$30M-13%
Q2 2026$14.7M-24%
Q1 2026$23M+$24M
Q4 2025$29M-9.5%
Q3 2025$34.3M+11%
Q2 2025$19.3M+22%
Q1 2025-$1M-114%
Q4 2024$32M+54%

AVPT has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.

ASTS Total Shares

Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
Q4 2023: 90MQ1 2024: 121MQ2 2024: 141MQ3 2024: 156MQ4 2024: 199MQ1 2025: 224MQ2 2025: 242MQ3 2025: 273MQ4 2025: 256MQ1 2026: 291MQ2 2026: 299MQ3 2026: 300M
PeriodChange %Net change
Quarterly+0.4%+1.1M shares
1 year+10%+27.3M shares
3 years+235%+211M shares
5 years+480%+248M shares
Available history+944%+271M shares

ASTS has 300M diluted shares, up 10% from a year ago.

AVPT Total Shares

Q4 2023: 182MQ1 2024: 181MQ2 2024: 183MQ3 2024: 204MQ4 2024: 184MQ1 2025: 225MQ2 2025: 229MQ3 2025: 233MQ4 2025: 229MQ1 2026: 226MQ2 2026: 221MQ3 2026: 222M
Q4 2023: 182MQ1 2024: 181MQ2 2024: 183MQ3 2024: 204MQ4 2024: 184MQ1 2025: 225MQ2 2025: 229MQ3 2025: 233MQ4 2025: 229MQ1 2026: 226MQ2 2026: 221MQ3 2026: 222M
PeriodChange %Net change
Quarterly+0.5%+1.1M shares
1 year-4.7%-10.9M shares
3 years+22%+40.2M shares
5 years+534%+187M shares

AVPT has the edge over ASTS on shareholder dilution, with a more favorable share count trend.

ASTS Net Leverage

ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

AVPT Net Leverage

ASTS Weekly Momentum

MetricValueStatus
RSI34.1Neutral
Stochastic11.9Oversold

ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).

AVPT Weekly Momentum

MetricValueStatus
RSI66.0Neutral
Stochastic83.1Overbought

AVPT's weekly RSI is 66 (neutral) and its Stochastic is 83 (overbought).

ASTS PE vs Technology Sector

ASTS has no meaningful PE right now: it lost money over the past year.

AVPT PE vs Technology Sector

MetricAVPTSector medianRelative
PE50x28x78% above
PE %183517 pts below

AVPT is trading at 50x earnings, a 78% premium to the Technology sector's median of 28x.

ASTS Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$44.923% below
20 week MA$57.140% below
50 week MA$75.554% below
100 week MA$57.840% below
200 week MA$33.62.8% above

ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.

AVPT Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$15.36.9% above
20 week MA$13.918% above
50 week MA$12.333% above
100 week MA$14.314% above
200 week MA$11.345% above

AVPT has the edge over ASTS on trend strength, trading above more of its moving averages.

ASTS Yearly ROI

YearStart priceEnd priceROI
2020$9.87$13.4+36%
2021$13.4$8.71-35%
2022$8.71$3.97-54%
2023$3.97$6.03+52%
2024$6.03$22.9+280%
2025$22.9$72.0+214%
2026 YTD$72.0$34.5-52%

ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.

AVPT Yearly ROI

YearStart priceEnd priceROI
2020$9.90$16.3+65%
2021$16.3$6.50-60%
2022$6.50$4.27-34%
2023$4.27$8.21+92%
2024$8.21$17.0+106%
2025$17.0$13.8-19%
2026 YTD$13.8$16.4+19%

AVPT has the edge over ASTS on returns for 2026, with the stronger performance.

Give your agent the market.

Get API key